Regarding liver diseases, CB1 and CB2 seem to play opposite roles, with CB2 exerting protective effects against the evolution of steatosis, inflammation, and fibrosis [2,3,4], and CB1 promoting these events instead [5]. This evidence concerns the gene CNR1 and steatosis.